Zolgensma Available Soon to Eligible SMA Type 1 Patients in England, Scotland

Mar 19, 2021, 12:00 AM

SMA News Today’s multimedia associate, Price Wooldridge, discusses Zolgenzma being added to the list of eligible medications for Spinal Muscular Atrophy (SMA) Type 1 patients in England and Scotland.
Also, despite a global pandemic complicating the process DeAnn Runge received her new wheelchair in record time. She did have to make compromises though and talks about getting used to going from rear-wheel drive to front wheel drive.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/